• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶。III。血清水平变化作为未经治疗的结节病疾病活动指标

Angiotensin converting enzyme. III. Changes in serum level as an indicator of disease activity in untreated sarcoidosis.

作者信息

Selroos O, Grönhagen-Riska C

出版信息

Scand J Respir Dis. 1979 Dec;60(6):328-36.

PMID:231819
Abstract

The activity of serum angiotensin converting enzyme (ACE) was repeatedly measured together with serum lysozyme (LZM) in patients with untreated sarcoidosis. Changes in the clinical picture were registered using chest X-ray, forced vital capacity (FVC), diffusing capacity for carbon monoxide (DLCO) and appearance of extrapulmonary lesions. During a clinically unchanged period the highest ACE activity and the corresponding LZM value (not the highest value) were used for the calculation. A statistically significant change in ACE was noted when a normal chest X-ray changed to a stage II lesion or vice versa, and when a signficant change in FVC occurred. All other changes were insignificant. On the other hand, statistically significant changes in ACE were found during stable periods according to chest X-ray, FVC or DLCO. ACE is frequently elevated in serum of patients with active sarcoidosis. The fluctuations in activity mostly parallel the clinical course of the disease. The behaviour and metabolism of the enzyme need further investigation. An increased concentration of serum LZM is frequent in patients with active sarcoidosis. The highest LZM values are not always seen simultaneously with the highest ACE values, indicating that they probably express different dimensions of the disturbances in the sarcoid granuloma.

摘要

对未经治疗的结节病患者反复测量血清血管紧张素转换酶(ACE)活性,并同时检测血清溶菌酶(LZM)。使用胸部X线、用力肺活量(FVC)、一氧化碳弥散量(DLCO)以及肺外病变的出现情况来记录临床表现的变化。在临床症状无变化的时期,采用最高的ACE活性及相应的LZM值(而非最高值)进行计算。当正常胸部X线转变为II期病变或反之,以及FVC出现显著变化时,ACE出现具有统计学意义的改变。所有其他变化均无统计学意义。另一方面,根据胸部X线、FVC或DLCO处于稳定期时,ACE也出现了具有统计学意义的变化。活动性结节病患者血清中的ACE常常升高。其活性波动大多与疾病的临床进程平行。该酶的行为和代谢需要进一步研究。活动性结节病患者血清LZM浓度常常升高。最高的LZM值并不总是与最高的ACE值同时出现,这表明它们可能反映了结节病肉芽肿病变的不同方面。

相似文献

1
Angiotensin converting enzyme. III. Changes in serum level as an indicator of disease activity in untreated sarcoidosis.血管紧张素转换酶。III。血清水平变化作为未经治疗的结节病疾病活动指标
Scand J Respir Dis. 1979 Dec;60(6):328-36.
2
67Ga scintigraphy, serum lysozyme and angiotensin-converting enzyme in pulmonary sarcoidosis.67镓闪烁扫描、血清溶菌酶及血管紧张素转换酶在肺结节病中的应用
Eur J Respir Dis. 1983 Jan;64(1):38-46.
3
Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis.矽肺和石棉肺中的血管紧张素转换酶与溶菌酶
Scand J Respir Dis. 1978 Aug;59(4):228-31.
4
Angiotensin-converting enzyme. I. Activity and correlation with serum lysozyme in sarcoidosis, other chest or lymph node diseases and healthy persons.血管紧张素转换酶。I. 结节病、其他胸部或淋巴结疾病及健康人中的活性及其与血清溶菌酶的相关性。
Scand J Respir Dis. 1979 Apr;60(2):83-93.
5
Angiotensin converting enzyme. V. Serum levels as monitors of disease activity in corticosteroid-treated sarcoidosis.血管紧张素转换酶。五、血清水平作为皮质类固醇治疗结节病疾病活动的监测指标。
Eur J Respir Dis. 1980 Apr;61(2):113-22.
6
Angiotensin converting enzyme. IV. Changes in serum activity and in lysozyme concentrations as indicators of the course of untreated sarcoidosis.
Scand J Respir Dis. 1979 Dec;60(6):337-44.
7
Blood monocytes and serum and bone marrow lysozyme in sarcoidosis.结节病中的血液单核细胞、血清及骨髓溶菌酶
Acta Med Scand. 1981;210(1-2):107-10. doi: 10.1111/j.0954-6820.1981.tb09784.x.
8
Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosis.肺结节病中溶菌酶、血管紧张素转换酶及其他炎症标志物的灌洗与血清测量对比
Eur Respir J. 1990 Nov;3(10):1146-54.
9
Serial observations of angiotensin-converting enzyme and pulmonary function in sarcoidosis.
Arch Intern Med. 1981 Jun;141(7):931-4.
10
Value of measuring serum angiotensin I converting enzyme and serum lysozyme in the management of sarcoidosis.测量血清血管紧张素I转换酶和血清溶菌酶在结节病管理中的价值。
Thorax. 1979 Feb;34(1):57-62. doi: 10.1136/thx.34.1.57.

引用本文的文献

1
Catch the rainbow: Prognostic factor of sarcoidosis.捕捉彩虹:结节病的预后因素。
Lung India. 2020 Sep-Oct;37(5):425-432. doi: 10.4103/lungindia.lungindia_380_19.
2
Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma.阿维鲁单抗治疗转移性默克尔细胞癌期间因结节病导致的高钙血症
Case Rep Oncol. 2019 Aug 8;12(2):639-643. doi: 10.1159/000502285. eCollection 2019 May-Aug.
3
Assessment of cardiac sarcoidosis with advanced imaging modalities.采用先进成像方式评估心脏结节病。
Biomed Res Int. 2014;2014:897956. doi: 10.1155/2014/897956. Epub 2014 Aug 28.
4
Angiotensin-converting enzyme and its clinical significance--a review.血管紧张素转换酶及其临床意义——综述
J Clin Pathol. 1983 Aug;36(8):938-47. doi: 10.1136/jcp.36.8.938.
5
Serum angiotensin converting enzyme in pulmonary disease.肺部疾病中的血清血管紧张素转换酶
Lung. 1982;160(6):287-301. doi: 10.1007/BF02719304.
6
Serum angiotensin converting enzyme in pneumonias.肺炎患者的血清血管紧张素转换酶
J Clin Pathol. 1986 Nov;39(11):1250-3. doi: 10.1136/jcp.39.11.1250.